Do popular drugs work the same for men and women? massive study investigates
NCT ID NCT07188545
Summary
This study uses existing health records from over 23 million people to see if two types of medications (GLP-1 agonists like Ozempic and SGLT2 inhibitors) work differently for men and women. It aims to find out if one sex gets more benefit in preventing heart attacks, strokes, kidney failure, and death. The goal is to gather knowledge to help ensure fair and effective treatment for everyone with related heart, kidney, and metabolic health risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University
Columbus, Ohio, 43202, United States
Conditions
Explore the condition pages connected to this study.